An antiviral medication which effectively inhibits replication of the coronavirus causing the COVID-19 and, at the same time, fights the immune reaction that is killing COVID-19 patients around the world.
This is the hope of a group of researchers headed by Christian Kanstrup Holm and David Olagnier who are behind a newly-published new study in the journal Nature Communications. The study shows that a drug called dimethyl fumarate (DMF), which is approved for the treatment of multiple sclerosis patients, inhibits the growth of a range of viruses in the body’s cells and that this includes the coronavirus (SARS-CoV2) – at least when the researchers test it in a test tube.
“As we’re doing basic research, we obviously don’t know whether the drug works on infections in humans, and it’s up to the infectious disease experts to test for this. However, I have to say that I’m very optimistic,” says